Sitagliptin Intermediates

Sitagliptin intermediates are important intermediate products in the synthesis of sitagliptin. Sitagliptin is a drug widely used in the treatment of type 2 diabetes. It works by inhibiting the DPP-4 enzyme, increasing the levels of endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), and promoting insulin secretion to achieve the effect of lowering blood sugar. The precise synthesis and quality control of sitagliptin intermediates are crucial for ensuring the efficacy and safety of sitagliptin, providing an effective means for blood glucose management in diabetic patients.